<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09240000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P10826</UniProt_ID>
  <Seq_Length>455</Seq_Length>
  <Molecule_Weight>50489</Molecule_Weight>
  <KEGG_ID>hsa:5915</KEGG_ID>
  <Orthology_ID>K08528</Orthology_ID>
  <Function_Summary>Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence or presence of hormone ligand, acts mainly as an activator of gene expression due to weak binding to corepressors. In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function.</Function_Summary>
  <Pfam_ID>PF00104:Hormone_recep@@PF00105:zf-C4</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>RAR-epsilon</Alias>
      <Alias>HBV-activated protein</Alias>
      <Alias>Nuclear receptor subfamily 1 group B member 2</Alias>
      <Alias>RAR-beta</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with a steroid hormone to initiate a change in cell activity.</Detail>
      <Keyword>Steroid hormone receptor activity</Keyword>
      <Ontology_ID>GO:0003707</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with retinoic acid to initiate a change in cell activity. Retinoic acid is one of the forms of vitamin A.</Detail>
      <Keyword>Retinoic acid receptor activity</Keyword>
      <Ontology_ID>GO:0003708</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.</Detail>
      <Keyword>Sequence-specific DNA binding</Keyword>
      <Ontology_ID>GO:0043565</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular function by which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>DNA binding</Keyword>
      <Ontology_ID>GO:0003677</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>90</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.</Detail>
      <Keyword>Embryonic digestive tract development</Keyword>
      <Ontology_ID>GO:0048566</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.</Detail>
      <Keyword>Transcription initiation from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0006367</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MTTSGHACPVPAVNGHMTHYPATPYPLLFPPVIGGLSLPPLHGLHGHPPPSGCSTPSPATIETQSTSSEELVPSPPSPLPPPRVYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMIYTCHRDKNCVINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKETSKQECTESYEMTAELDDLTEKIRKAHQETFPSLCQLGKYTTNSSADHRVRLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLICGDRQDLEEPTKVDKLQEPLLEALKIYIRKRRPSKPHMFPKILMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGHEPLTPSSSGNTAEHSPSISPSSVENSGVSQSPLVQ</Protein_Seq>
    <DNA_Seq>TGCGAGCTGTTTGAGGACTGGGATGCCGAGAACGCGAGCGATCCGAGCAGGGTTTGTCTGGGCACCGTCGGGGTAGGATCCGGAACGCATTCGGAAGGCTTTTTGCAAGCATTTACTTGGAAGGAGAACTTGGGATCTTTCTGGGAACCCCCCGCCCCGGCTGGATTGGCCGAGCAAGCCTGGAAAATGGTAAATGATCATTTGGATCAATTACAGGCTTTTAGCTGGCTTGTCTGTCATAATTCATGATTCGGGGCTGGGAAAAAGACCAACAGCCTACGTGCCAAAAAAGGGGCAGAGTTTGATGGAGTTGGGTGGACTTTTCTATGCCATTTGCCTCCACACCTAGAGGATAAGCACTTTTGCAGACATTCAGTGCAAGGGAGATCATGTTTGACTGTATGGATGTTCTGTCAGTGAGTCCTGGGCAAATCCTGGATTTCTACACTGCGAGTCCGTCTTCCTGCATGCTCCAGGAGAAAGCTCTCAAAGCATGCTTCAGTGGATTGACCCAAACCGAATGGCAGCATCGGCACACTGCTCAATCAATTGAAACACAGAGCACCAGCTCTGAGGAACTCGTCCCAAGCCCCCCATCTCCACTTCCTCCCCCTCGAGTGTACAAACCCTGCTTCGTCTGCCAGGACAAATCATCAGGGTACCACTATGGGGTCAGCGCCTGTGAGGGATGTAAGGGCTTTTTCCGCAGAAGTATTCAGAAGAATATGATTTACACTTGTCACCGAGATAAGAACTGTGTTATTAATAAAGTCACCAGGAATCGATGCCAATACTGTCGACTCCAGAAGTGCTTTGAAGTGGGAATGTCCAAAGAATCTGTCAGGAATGACAGGAACAAGAAAAAGAAGGAGACTTCGAAGCAAGAATGCACAGAGAGCTATGAAATGACAGCTGAGTTGGACGATCTCACAGAGAAGATCCGAAAAGCTCACCAGGAAACTTTCCCTTCACTCTGCCAGCTGGGTAAATACACCACGAATTCCAGTGCTGACCATCGAGTCCGACTGGACCTGGGCCTCTGGGACAAATTCAGTGAACTGGCCACCAAGTGCATTATTAAGATCGTGGAGTTTGCTAAACGTCTGCCTGGTTTCACTGGCTTGACCATCGCAGACCAAATTACCCTGCTGAAGGCCGCCTGCCTGGACATCCTGATTCTTAGAATTTGCACCAGGTATACCCCAGAACAAGACACCATGACTTTCTCAGACGGCCTTACCCTAAATCGAACTCAGATGCACAATGCTGGATTTGGTCCTCTGACTGACCTTGTGTTCACCTTTGCCAACCAGCTCCTGCCTTTGGAAATGGATGACACAGAAACAGGCCTTCTCAGTGCCATCTGCTTAATCTGTGGAGACCGCCAGGACCTTGAGGAACCGACAAAAGTAGATAAGCTACAAGAACCATTGCTGGAAGCACTAAAAATTTATATCAGAAAAAGACGACCCAGCAAGCCTCACATGTTTCCAAAGATCTTAATGAAAATCACAGATCTCCGTAGCATCAGTGCTAAAGGTGCAGAGCGTGTAATTACCTTGAAAATGGAAATTCCTGGATCAATGCCACCTCTCATTCAAGAAATGCTGGAGAATTCTGAAGGACATGAACCCTTGACCCCAAGTTCAAGTGGGAACACAGCAGAGCACAGTCCTAGCATCTCACCCAGCTCAGTGGAAAACAGTGGGGTCAGTCAGTCACCACTCGTGCAATAAGACATTTTCTAGCTACTTCAAACATTCCCCAGTACCTTCAGTTCCAGGATTTAAAATGCAAGAAAAAACATTTTTACTGCTGCTTAGTTTTTGGACTGAAAAGATATTAAAACTCAAGAAGGACCAAGAAGTTTTCATATGTATCAATATATATACTCCTCACTGTGTAACTTACCTAGAAATACAAACTTTTCCAATTTTAAAAAATCAGCCATTTCATGCAACCAGAAACTAGTTAAAAGCTTCTATTTTCCTCTTTGAACACTCAAGATTGCATGGCAAAGACCCAGTCAAAATGATTTACCCCTGGTTAAGTTTCTGAAGACTTTGTACATACAGAAGTATGGCTCTGTTCTTTCTATACTGTATGTTTGGTGCTTTCCTTTTGTCTTGCATACTCAAAATAACCATGACACCAAGGTTATGAAATAGACTACTGTACACGTCTACCTAGGTTCAAAAAGATAACTGTCTTGCTTTCATGGAATAGTCAAGACATCAAGGTAAGGAAACAGGACTATTGACAGGACTATTGTACAGTATGACAAGATAAGGCTGAAGATATTCTACTTTAGTTAGTATGGAAGCTTGTCTTTGCTCTTTCTGATGCTCTCAAACTGCATCTTTTATTTCATGTTGCCCAGTAAAAGTATACAAATTCCCTGCACTAGCAGAAGAGAATTCTGTATCAGTGTAACTGCCAGTTCAGTTAATCAAATGTCATTTGTTCAATTGTTAATGTCACTTTAAATTAAAAGTGGTTTATTACTTGTTTAATGACATAACTACACAGTTAGTTAAAAAAAATTTTTTTACAGTAATGATAGCCTCCAAGGCAGAAACACTTTTCAGTGTTAAGTTTTTGTTTACTTGTTCACAAGCCATTAGGGAAATTTCATGGGATAATTAGCAGGCTGGTCTACCACCTGGACCATGTAACTCTAGTGTCCTTCCTGATTCATGCCTGATATTGGGATTTTTTTTTCCAGCCTTCTTGATGCCAAGGGGCTAATTAATATTAACAACTCCCAAAGAAACAGGCATAGAATCTGCCTCCTTTGACCTTGTTCAATCACTATGAAGCAGAGTGAAAGCTGTGGTAGAGTGGTTAACAGATACAAGTGTCAGTTTCTTAGTTCTCATTTAAGCACTAGTGGAATTTTTTTTTTTTGATATATTAGCAAGTCTGTGATGTACTTTCACTGGCTCTGTTTGTACATTGAGATTGTTTGTTTAACAATGCTTTCTATGTTCATATACTGTTTACCTTTTTCCATGGAGTCTCCTGGCAAAGAATAAAATATATTTATTTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
      <Ontology_ID>GO:0005654</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>RARB</Gene_Name>
    <Gene_Alias>HAP; NR1B2</Gene_Alias>
    <Gene_ID>5915</Gene_ID>
    <Genbank_ACCN>NM_000965</Genbank_ACCN>
    <Protein_ACCN>NP_000956</Protein_ACCN>
    <HGNC_ID>9865</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5915</Gene_URL>
    <UCSC_ID>uc003cdi.2</UCSC_ID>
    <EMBL_ID>ENSG00000077092</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Craniopharyngioma</Disease_Name>
      <Disease_Detail>Craniopharyngioma</Disease_Detail>
      <Disease_DB>CRN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/craniopharyngioma?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Partial Lipodystrophy</Disease_Name>
      <Disease_Detail>Familial Partial Lipodystrophy</Disease_Detail>
      <Disease_DB>FML012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_partial_lipodystrophy?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Matthew-Wood Syndrome</Disease_Name>
      <Disease_Detail>Matthew-Wood Syndrome</Disease_Detail>
      <Disease_DB>MTT005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/matthew_wood_syndrome?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatitis</Disease_Name>
      <Disease_Detail>Hepatitis</Disease_Detail>
      <Disease_DB>HPT021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatitis?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lichen Sclerosus</Disease_Name>
      <Disease_Detail>Lichen Sclerosus</Disease_Detail>
      <Disease_DB>LCH009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lichen_sclerosus?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Esophageal Cancer</Disease_Name>
      <Disease_Detail>Esophageal Cancer</Disease_Detail>
      <Disease_DB>ESP021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/esophageal_cancer?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Variant Creutzfeldt-Jakob Disease</Disease_Name>
      <Disease_Detail>Variant Creutzfeldt-Jakob Disease</Disease_Detail>
      <Disease_DB>VRN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/variant_creutzfeldt_jakob_disease?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chromosome 3p Deletion</Disease_Name>
      <Disease_Detail>Chromosome 3p Deletion</Disease_Detail>
      <Disease_DB>CHR243</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chromosome_3p_deletion?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Adenoma</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_adenoma?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukoplakia</Disease_Name>
      <Disease_Detail>Leukoplakia</Disease_Detail>
      <Disease_DB>LKP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukoplakia?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Microphthalmia, Syndromic 12</Disease_Name>
      <Disease_Detail>Microphthalmia, Syndromic 12</Disease_Detail>
      <Disease_DB>MCR212</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/microphthalmia_syndromic_12?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatocellular Carcinoma</Disease_Name>
      <Disease_Detail>Hepatocellular Carcinoma</Disease_Detail>
      <Disease_DB>HPT023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatocellular_carcinoma?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatitis B</Disease_Name>
      <Disease_Detail>Hepatitis B</Disease_Detail>
      <Disease_DB>HPT016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatitis_b?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=RARB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Choroid Plexus Papilloma</Disease_Name>
      <Disease_Detail>Choroid Plexus Papilloma</Disease_Detail>
      <Disease_DB>CHR029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/choroid_plexus_papilloma?search=RARB#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>THE SOLUTION STRUCTURE OF THE HUMAN RETINOIC ACID RECEPTOR-BETA DNA-BINDING DOMAIN</PDB_Title>
      <PDB_ID>1HRA</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HRA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structure of the human retinoic acid receptor-beta DNA-binding domain.</PubMed_Title>
      <Author>Knegtel, R.M., et al.</Author>
      <Journal>J.Biomol.NMR(1993)3:1-17</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8383553?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the ligand binding domain of the Retinoic Acid Receptor beta</PDB_Title>
      <PDB_ID>1XAP</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XAP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Rational design of RAR-selective ligands revealed by RARbeta crystal stucture</PubMed_Title>
      <Author>Germain, P., et al.</Author>
      <Journal>Embo Rep.(2004)5:877-882</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15319780?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of RARb LBD in complex with 9cis retinoic acid</PDB_Title>
      <PDB_ID>4DM8</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DM8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02570008</ASD_Ligand>
      <PubMed_Title>Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors.</PubMed_Title>
      <Author>Osz, J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2012)109:E588-E594</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22355136?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of RARb LBD homodimer in complex with TTNPB</PDB_Title>
      <PDB_ID>4DM6</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DM6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02570003</ASD_Ligand>
      <PubMed_Title>Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors.</PubMed_Title>
      <Author>Osz, J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2012)109:E588-E594</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22355136?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05223</Pathway_ID>
      <Pathway_Title>Non-small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.cdh.b.b.eb.html</SCOP_URL>
    <CATH_Class>Class 1: Mainly Alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1xap</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Dimerization</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02570003</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02570008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>